Global Flow Cytometry Market Forecast Until 2025|Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies

Global flow cytometry market is expected to reach at a CAGR of 8.3% in the forecast period of 2018 to 2025.

Flow cytometry market research report works as a precious source of information with which businesses can accomplish a telescopic view of the current market trends, consumer’s demands and preferences, market situations, opportunities and market status. In addition, it also comprises all the information including market definition, classifications, key developments, applications, and engagements along with the detailed actions of key players with respect to product launches, joint ventures, developments, mergers and acquisitions and effects of the same in terms of sales, import, export, revenue and CAGR values. The flow cytometry report provides all-inclusive study of current situation of the large-scale market along with several market dynamics.

Access Sample Copy of Research Report: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-flow-cytometry-market

.Competitive Analysis: 

Some of the major players operating in this market are Bio-Rad Laboratories, Inc., Miltenyi Biotec Sysmex Partec GmbH, BIOMÉRIEUX, Mechatronics,, Apogee Flow Systems Ltd., Stratedigm, Inc., Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies , Luminex Corporation. , Enzo Life Sciences, Inc., Beckman Coulter, Inc., Takara Bio Inc. among others.

Table of Contents

Introduction

1.Market Segmentation

2.Market Overview

3.Executive Summary

4.Premium Insights

5.Global, By Component

6.Product Type

7.Delivery

8.Industry Type

9.Geography

Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-flow-cytometry-market

Segmentation: Global Flow Cytometry Market

Global flow cytometry market is segmented into four notable segments which are technology, products, end user and application.

On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. Cell-based flow cytometry is dominating the market and bead-based flow cytometry segment is growing at the highest CAGR in the forecast period of 2018 to 2025.

In April 2018, Merck KGaA (Germany) launched its new Cell Stream benchtop flow cytometry system which is a compressed, customizable flow cytometer that use a camera for detection. It is a unique optics system and design provides researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. With this launch of the product company has expanded their product line in flow cytometers.

On the basis of products, the market is segmented into categorized into reagents and consumables, flow cytometry instruments, accessories and services. The segment reagents and consumables are further sub segmented into antibodies, dyes, beads and others. The segment flow cytometry instruments are further sub segmented into cell analyzers and cell sorters. The segment services are further sub segmented into filters, laser devices, detectors and others. Flow cytometry instruments segment is growing at the highest CAGR in the forecast period of 2018 to 2025.

In February 2014, Bio-Rad Laboratories, Inc. (U.S.), announced the launch of its ReadiLink antibody labeling kits, one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50-100 µg) of antibody. These kits are ideal for researchers interested in labelling their own antibodies for flow cytometry and cell sorting applications.

On the basis of application, the market is segmented into research applications, clinical application and industrial applications. Research application market is further sub segmented into pharmaceutical and biotechnology, immunology, apoptosis, cell sorting/ screening, cell cycle analysis, cell transfection/viability, cell counting, other research applications. Pharmaceutical and biotechnology are further segmented into drug discovery, stem cell research, in vitro toxicity testing. The clinical applications are further sub segmented into cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Clinical application segment is growing at the highest CAGR in the forecast period of 2018 to 2025.

In September 2017, Beckman Coulter, Inc. (U.S.), has launch their first flow cytometry CytoFLEX LX for the cancer researchers which has the visible spectrum in a standard configuration. From this launch of the product they have expanded their business in flow cytometry.

On the basis of end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinical testing laboratories, blood bank and others. Academic & research institutes segment is growing at the highest CAGR in the forecast period of 2018 to 2025.

In July 2017, Beckman Coulter, Inc. (U.S.), has received U.S. FDA approval for its clinical flow cytometry product, the Navios EX flow cytometer, to be used in the clinical laboratory in the US.  The Navios EX delivers accurate, high complexity immunophenotyping using Tetra reagents. The compact, 10-color Navios EX incorporates the advanced optics and laser technology of the company’s award-winning CytoFLEX research flow cytometer. From this clearance Beckman Coulter, Inc. has enhanced their product portfolio in flow cytometry.

Any inquiry, Speak to Our Expert: https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-flow-cytometry-market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.